A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses

Triple-negative breast cancer is a heterogeneous disease characterized by a lack of hormonal receptors and HER2 overexpression. It is the only breast cancer subgroup that does not benefit from targeted therapies, and its prognosis is poor. Several studies have developed specific molecular classifica...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Rep
Autors principals: Prado-Vázquez, Guillermo, Gámez-Pozo, Angelo, Trilla-Fuertes, Lucía, Arevalillo, Jorge M., Zapater-Moros, Andrea, Ferrer-Gómez, María, Díaz-Almirón, Mariana, López-Vacas, Rocío, Navarro, Hilario, Maín, Paloma, Feliú, Jaime, Zamora, Pilar, Espinosa, Enrique, Fresno Vara, Juan Ángel
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6367406/
https://ncbi.nlm.nih.gov/pubmed/30733547
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-018-38364-y
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars